CCI Welcomes Pharmascience Inc. to Our National Network of Innovators

The Council of Canadian Innovators (CCI) is proud to welcome Pharmascience Inc. and Executive Chairman Dr. David Goodman to Canada’s national network of high-growth companies shaping the future of health and life sciences.

Headquartered in Montreal, Quebec, Pharmascience is a fully integrated life sciences company that develops, manufactures, packages, and distributes high-quality pharmaceutical products for both domestic and international markets. As the largest Canadian-owned pharmaceutical company, Pharmascience plays a vital role in supporting patients and healthcare systems in Canada and around the world.

Through its divisions, Pharmascience delivers innovative solutions including generic and specialty medicines, export-ready treatments, and contract manufacturing services, all of which strengthen Canada’s pharmaceutical sovereignty. The company is committed to ensuring access, quality, and resilience across the country’s healthcare ecosystem.

Dr. David Goodman, Executive Chairman of Pharmascience, continues a decades-long commitment to advancing life sciences in Canada and championing local innovation in a globally competitive sector.

“Pharmascience brings deep capabilities and a national perspective to Canada’s life sciences economy,” said CCI President Benjamin Bergen. “They are a great example of how Canadian companies are building for long-term health, resilience, and global impact.”

Since 2015, the Council of Canadian Innovators has been dedicated to supporting Canada’s high-growth technology companies, working with government leaders to co-develop strategies that unlock the full potential of the country’s innovation ecosystem.